Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes

These results suggest that Sorafenib and Regorafenib treatments offer a survival advantage in patients with relapsed HCC post-transplantation. However, individualized treatment strategies and close follow-up are crucial for optimizing outcomes. Further studies are needed to refine therapeutic protocols and enhance the care of this specific patient group.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2024-11-20
DOI
https://doi.org/10.3390/cancers16223880
Citations
4
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
1.48
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes

Ahmet Bılıcı, Cihan Erol, Fatih Teker, Ziya Kalkan et al.
4 citations
Cancers
Hepatocellular Carcinoma Treatment and Prognosis
1.48
article

Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes

Ahmet Bılıcı, Cihan Erol, Fatih Teker, Ziya Kalkan, Ali Murat Tatlı, İlkay Gültürk, Ömer Tekin, Timuçin Çil, Mehmet Alı Nahıt Şendur, Oğuzhan Selvi, Caglayan Geredeli, Ertuğrul Bayram, Sezer Sağlam, Kaplan Ma, Mehmet Fatih Ozbay, Mustafa Karaca, Sema Sezgin Göksu, Hakan Harputluoğlu, Deniz Tural, Berksoy Şahin
article en
4 citations

Abstract

These results suggest that Sorafenib and Regorafenib treatments offer a survival advantage in patients with relapsed HCC post-transplantation. However, individualized treatment strategies and close follow-up are crucial for optimizing outcomes. Further studies are needed to refine therapeutic protocols and enhance the care of this specific patient group.

CancersVol. 16(22)
Dicle University (TR), Ministry of Health (TR), Istanbul Bilim University (TR), Akdeniz University (TR), Inonu University (TR), Istanbul Medipol University (TR), Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi (TR), Sağlık Bilimleri Üniversitesi (TR), Okmeydanı Eğitim ve Araştırma Hastanesi (TR), Ankara Bilkent City Hospital (TR), Cukurova University (TR), Gaziantep University (TR)
Good health and well-being
Openalex Percentile: Top 17%
Hepatocellular Carcinoma Treatment and Prognosis
1.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.